Advertisement

enVVeno Medical Corporation NVNO

Set alert

Price alert · NVNO

All alert types
6.73 USD -0.29 -4.13%

At close · Oct 30

7.23 +0.50 +7.43%

After hours · Oct 30, 4:00 PM ET

Bid
6.72 × 1
Ask
7.26 × 3
6.70 Day range 7.11
6.65 52-week range 24.85
YTD
-40.07%
1 year
-72.42%
Open
6.87
Prev close
7.02
Mkt cap
4.68M
Vol
19.18K
Avg vol
28.14K
EPS
-24.99
P/E
0.00
Div yield
0.00%
More statistics
Low
6.70
High
7.11
Forward P/E
-2.45
Beta
1.22
Short ratio
4.12
Inst. own
29.76%
Dividend
0.00
Ex-div date
Earnings
Jul 31, 2024
50-d avg
3.22
200-d avg
4.62
1y target
18.00

2Y chart

Chart tools
Interval

Events in this range
  • Jan 20, 2026Split: 1 for 35
Signals (93)
NameDateAgo
MACD: Buy SignalOct 30, 20261 day ago
MACD: Sell SignalOct 22, 20261 week ago
MACD: Buy SignalOct 19, 20261 week ago
MACD: Sell SignalOct 16, 20262 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OversoldSep 30, 20261 month ago
SMA: BearishSep 11, 20261 month ago
SMA: BearishSep 11, 20261 month ago
MACD: Sell SignalSep 11, 20261 month ago
SMA: BullishSep 2, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 31, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 26, 20262 months ago
MACD: Buy SignalAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
MACD: Sell SignalAug 20, 20262 months ago
SMA: BearishAug 19, 20262 months ago
SMA: BullishAug 11, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago
MACD: Sell SignalAug 10, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 3, 20262 months ago
MACD: Buy SignalAug 3, 20262 months ago
SMA: BearishJul 28, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 21, 20263 months ago
SMA: BullishJul 17, 20263 months ago
SMA: BearishJul 16, 20263 months ago
MACD: Sell SignalJul 15, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BearishJun 30, 20264 months ago
SMA: BullishJun 24, 20264 months ago
MACD: Buy SignalJun 24, 20264 months ago
MACD: Sell SignalJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 20, 20265 months ago
MACD: Buy SignalMay 20, 20265 months ago
SMA: BearishApr 29, 20266 months ago
MACD: Sell SignalApr 29, 20266 months ago
MACD: Buy SignalApr 9, 20266 months ago
SMA: BullishApr 8, 20266 months ago
SMA: BearishMar 26, 20267 months ago
SMA: BullishMar 25, 20267 months ago
SMA: BearishMar 23, 20267 months ago
MACD: Sell SignalMar 23, 20267 months ago
SMA: BullishMar 17, 20267 months ago
SMA: BearishMar 13, 20267 months ago
SMA: BullishMar 5, 20268 months ago
SMA: BearishFeb 25, 20268 months ago
SMA: BullishFeb 20, 20268 months ago
MACD: Buy SignalFeb 19, 20268 months ago
MACD: Sell SignalFeb 4, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BullishJan 30, 20269 months ago
MACD: Buy SignalJan 30, 20269 months ago
MACD: Sell SignalJan 27, 20269 months ago
RSI: OversoldDec 8, 202510 months ago
MACD: Buy SignalNov 28, 202511 months ago
MACD: Sell SignalNov 17, 202511 months ago
RSI: OversoldNov 14, 202511 months ago
RSI: OversoldNov 6, 202511 months ago
RSI: OversoldNov 4, 202512 months ago
RSI: OversoldOct 30, 20251 year ago
RSI: OversoldOct 21, 20251 year ago
RSI: OversoldOct 10, 20251 year ago
MACD: Buy SignalSep 10, 20251 year ago
RSI: OversoldAug 20, 20251 year ago
SMA: BearishAug 19, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
MACD: Buy SignalJul 17, 20251 year ago
RSI: OverboughtJul 17, 20251 year ago
MACD: Sell SignalJun 20, 20251 year ago
MACD: Buy SignalJun 9, 20251 year ago
MACD: Sell SignalMay 21, 20251 year ago
RSI: OverboughtMay 13, 20251 year ago
RSI: OverboughtMay 1, 20251 year ago
SMA: BullishApr 29, 20251 year ago
MACD: Buy SignalApr 16, 20251 year ago
RSI: OversoldApr 10, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
MACD: Sell SignalMar 28, 20251 year ago
MACD: Buy SignalMar 24, 20251 year ago
SMA: BearishFeb 28, 20251 year ago
MACD: Sell SignalFeb 28, 20251 year ago
RSI: OverboughtFeb 20, 20251 year ago
MACD: Buy SignalFeb 13, 20251 year ago
SMA: BullishFeb 12, 20251 year ago
SMA: BearishFeb 6, 20251 year ago
MACD: Sell SignalJan 28, 20251 year ago
SMA: BullishJan 15, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago
RSI: OversoldDec 18, 20241 year ago

Key statistics

Market cap
51.03M
Enterprise value
-3.57M
Trailing P/E
0.00
Forward P/E
-2.45
PEG ratio
0.00
Price / sales
0.00
Price / book
1.08
EPS (TTM)
-1.29
Beta
1.22
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-9.84M
Total cash
48.38M
Total debt
1.15M
Return on equity
-58.77%
Shares outstanding
17.54M
Short % of float
2.74%
50-day average
3.22
200-day average
4.62

Analyst view

Consensus: none

Price target (mean) 18.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Jul 31, 2024

Expected Jul 31, 2024. Consensus EPS estimate -0.35.

Earnings history

Financials — quick view

All financials
NVNO Revenue — quarterly 0
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
NVNO Net income — quarterly -4.37M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
NVNO EPS — quarterly -6.29
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

NVNO recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 30, 2024Sep 1, 20240.00-0.35——
Jul 31, 2024Jun 1, 20240.00-0.31——
Jul 31, 2024Jun 1, 20240.00———
May 8, 2024Mar 1, 20240.00-0.31——
May 8, 2024Mar 1, 20240.00———
Feb 29, 2024Dec 1, 20230.00-0.32——

About enVVeno Medical Corporation

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
envveno.com

News

Your note

Sign in to keep a note on NVNO — it syncs with the Stock Master app.

Insider holders

NVNO insider holders
InsiderRelationLatest transactionDateShares held
ALAVI HAMEDChief Technology OfficerSaleMar 12, 20240
BERMAN ROBERT ANDREWChief Executive OfficerPurchaseDec 18, 2024222,236

Institution ownership

NVNO institution ownership
Holder% heldSharesValueReported
Kingdon Capital Management LLC4.90%859,2612.50MSep 29, 2024
Perceptive Advisors Llc3.96%694,3152.02MSep 29, 2024
Nantahala Capital Management, LLC3.40%596,9171.74MSep 29, 2024
Vanguard Group Inc3.36%589,1411.71MSep 29, 2024
Alyeska Investment Group, L.p.2.42%425,0001.24MSep 29, 2024
Adar1 Capital Management, LLC 1.99%348,2631.01MSep 29, 2024

Fund ownership

NVNO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.39%418,5361.22MSep 29, 2024
Vanguard Extended Market Index Fund0.89%156,171454.46KSep 29, 2024
Fidelity Extended Market Index Fund0.43%75,500219.71KOct 30, 2024
Fidelity Total Market Index Fund0.14%23,98469.79KOct 30, 2024
iShares Micro Cap ETF0.14%23,87969.49KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.12%20,48759.62KOct 30, 2024
Advertisement